783 related articles for article (PubMed ID: 26049704)
1. Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study.
Carpio D; Barreiro-de Acosta M; Echarri A; Pereira S; Castro J; Ferreiro R; Lorenzo A;
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1030-7. PubMed ID: 26049704
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.
Parente JM; Coy CS; Campelo V; Parente MP; Costa LA; da Silva RM; Stephan C; Zeitune JM
World J Gastroenterol; 2015 Jan; 21(4):1197-206. PubMed ID: 25632193
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of hospital admissions of patients with ulcerative colitis and Crohn's disease from semi-rural and rural regions in the Department of Gastroenterology in Lublin between 2000- 2006.
Skrzydło-Radomańska B; Radwan P; Radwan-Kwiatek K
Ann Agric Environ Med; 2008; 15(2):193-7. PubMed ID: 19061254
[TBL] [Abstract][Full Text] [Related]
5. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
6. Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011.
Lovasz BD; Lakatos L; Horvath A; Pandur T; Erdelyi Z; Balogh M; Szipocs I; Vegh Z; Veres G; Müller KE; Golovics PA; Kiss LS; Mandel MD; Lakatos PL
Dig Liver Dis; 2014 May; 46(5):405-11. PubMed ID: 24495511
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
Busingye D; Pollack A; Chidwick K
PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730
[TBL] [Abstract][Full Text] [Related]
8. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease.
Benchimol EI; Mack DR; Nguyen GC; Snapper SB; Li W; Mojaverian N; Quach P; Muise AM
Gastroenterology; 2014 Oct; 147(4):803-813.e7; quiz e14-5. PubMed ID: 24951840
[TBL] [Abstract][Full Text] [Related]
9. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.
Vavricka SR; Brun L; Ballabeni P; Pittet V; Prinz Vavricka BM; Zeitz J; Rogler G; Schoepfer AM
Am J Gastroenterol; 2011 Jan; 106(1):110-9. PubMed ID: 20808297
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and temporal trends (2000-2012) of inflammatory bowel disease in adult patients in a central region of Spain.
Lucendo AJ; Hervías D; Roncero Ó; Lorente R; Bouhmidi A; Angueira T; Verdejo C; Salueña I; González-Castillo S; Arias Á
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1399-407. PubMed ID: 25341061
[TBL] [Abstract][Full Text] [Related]
11. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
[TBL] [Abstract][Full Text] [Related]
12. Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea.
Chung SH; Park SJ; Lee HS; Hong SP; Cheon JH; Kim TI; Kim WH
World J Gastroenterol; 2014 Dec; 20(45):17120-6. PubMed ID: 25493025
[TBL] [Abstract][Full Text] [Related]
13. Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003.
Vijverman A; Piront P; Belaiche J; Louis E
Acta Gastroenterol Belg; 2006; 69(1):1-4. PubMed ID: 16673554
[TBL] [Abstract][Full Text] [Related]
14. Better survival of renal cell carcinoma in patients with inflammatory bowel disease.
Derikx LA; Nissen LH; Drenth JP; van Herpen CM; Kievit W; Verhoeven RH; Mulders PF; Hulsbergen-van de Kaa CA; Boers-Sonderen MJ; van den Heuvel TR; Pierik M; Nagtegaal ID; Hoentjen F; ; ;
Oncotarget; 2015 Nov; 6(35):38336-47. PubMed ID: 26447542
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
16. Smoking increases the risk of extraintestinal manifestations in Crohn's disease.
Ott C; Takses A; Obermeier F; Schnoy E; Müller M
World J Gastroenterol; 2014 Sep; 20(34):12269-76. PubMed ID: 25232261
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
18. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
[TBL] [Abstract][Full Text] [Related]
19. [Incidence and prevalence of inflammatory bowel disease in Gijon, Asturias, Spain].
Saro Gismera C; Lacort Fernández M; Argüelles Fernández G; Antón Magarzo J; García López R; Navascues CA; Suárez González A; Díaz Alvarez G; González Bernal A; Palacios Galán A; Altadill Arregui A; Vizoso F
Gastroenterol Hepatol; 2000; 23(7):322-7. PubMed ID: 11002532
[TBL] [Abstract][Full Text] [Related]
20. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort.
Greuter T; Porchet F; Braga-Neto MB; Rossel JB; Biedermann L; Schreiner P; Scharl M; Schoepfer AM; Safroneeva E; Straumann A; Rogler G; Vavricka SR
United European Gastroenterol J; 2020 Dec; 8(10):1196-1207. PubMed ID: 33276710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]